文献速递膀胱癌与上尿路尿路上皮癌

旅行距离、医院手术量与肌层浸润性膀胱癌根治性膀胱切除术后结局的关联

Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer.
PubMed 文献 · Urology · 2018-01-02

基于美国国家癌症数据库2006至2013年6551例接受根治性膀胱切除术的肌层浸润性膀胱癌患者,多变量回归分析显示,当同时纳入旅行距离和医院手术量时,仅医院手术量与总生存改善相关。结论提示距离偏倚效应主要由医院手术量介导,支持将根治性膀胱切除术集中于高手术量医院。

要点

  • 单独分析时,旅行距离和医院手术量最高四分位均与总生存改善相关。
  • 同时纳入两变量后,仅医院手术量与总生存改善独立相关。
  • 高手术量医院患者更可能接受新辅助化疗、清扫≥10枚淋巴结,但手术延迟>3个月几率更高。

核心结论

  • 根治性膀胱切除术后较长旅行距离与总生存改善的关联(距离偏倚效应)主要由较高医院手术量介导。
  • 在高手术量医院行根治性膀胱切除术的获益可能超过较长旅行距离的潜在劣势,支持继续推进肌层浸润性膀胱癌的区域化诊疗。

研究设计与样本

  • 基于美国国家癌症数据库2006至2013年数据的回顾性队列研究,最终纳入6551例接受根治性膀胱切除术的肌层浸润性膀胱癌患者。
  • 采用多变量回归模型,分别单独纳入旅行距离、单独纳入医院手术量、以及同时纳入两者进行分析,两变量均按四分位数分组。

主要发现

  • 仅纳入旅行距离或仅纳入医院手术量的模型中,两变量的最高四分位均与总生存改善相关。
  • 同时纳入旅行距离和医院手术量后,仅医院手术量与总生存相关;将两变量作为连续变量进行敏感性分析结果相似。
  • 校正旅行距离后,在高手术量医院接受根治性膀胱切除术的患者更可能接受新辅助化疗、清扫10枚或以上淋巴结,但手术延迟(>3个月)的几率也更高。

临床怎么用

  • 肌层浸润性膀胱癌行根治性膀胱切除术应优先考虑高手术量医院,而非因距离因素选择低手术量机构。
  • 高手术量医院在提高新辅助化疗和淋巴结清扫质量的同时,需关注并减少手术延迟(>3个月)的风险。

局限性

  • 原文摘要未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the associations between travel distance, hospital volume, and outcomes following radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC). METHOD: The 2006 to 2013 National Cancer Database was queried to identify patients with MIBC who underwent RC. Multivariable regressions alternately including travel distance, hospital volume, and both in the models were used. Travel distances and hospital volumes were categorized by quartiles. Outcomes of interest were overall survival and quality-of-care indicators. RESULT: A total of 6551 patients were included in the final cohort. When only travel distance or hospital volume was included in the multivariable regression model, fourth quartiles of both variables were associated with improved overall survival. When both travel distance and hospital volume were included in the model, only hospital volume was found to be associated with overall survival. Sensitivity analyses with both travel distance and hospital volume considered as continuous variables showed similar results. Patients who underwent RC in high-volume hospitals were more likely to receive neoadjuvant chemotherapy, have 10 or more lymph nodes removed, but also had higher odds of surgical delay (>3 months) in the full models adjusting for travel distance. CONCLUSION: This National Cancer Database-based study suggests that the association between longer travel distance and improved overall survival (distance bias effect) after RC for MIBC is mainly mediated by higher hospital volume. The benefits of having RC at high-volume hospitals may outweigh the potential disadvantages of longer travel distance, which further supports the continued regionalization of RC and cancer care for MIBC.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Xia L, Taylor BL, Mamtani R, et al. Associations Between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer. Urology. 2018. PMID: 29305205. doi:10.1016/j.urology.2017.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。